Paracrine Fibroblast Growth Factor 1 Functions as Potent Therapeutic Agent for Intrahepatic Cholestasis by Downregulating Synthesis of Bile Acid

por Lin, Huan, Zhou, Chuanren, Hou, Yushu, Li, Qi, Qiao, Guanting, Wang, Yang, Huang, Zhifeng, Niu, Jianlou
Publicado 2019

The novel estrogenic receptor GPR30 alleviates ischemic injury by inhibiting TLR4-mediated microglial inflammation

por Zhang, Zengli, Qin, Pei, Deng, Youliang, Ma, Zhi, Guo, Hang, Guo, Haiyun, Hou, Yushu, Wang, Shiquan, Zou, Wangyuan, Sun, Yanyuan, Ma, Yulong, Hou, Wugang
Publicado 2018

Paracrine FGFs target skeletal muscle to exert potent anti-hyperglycemic effects

por Ying, Lei, Wang, Luyao, Guo, Kaiwen, Hou, Yushu, Li, Na, Wang, Shuyi, Liu, Xingfeng, Zhao, Qijin, Zhou, Jie, Zhao, Longwei, Niu, Jianlou, Chen, Chuchu, Song, Lintao, Hou, Shaocong, Kong, Lijuan, Li, Xiaokun, Ren, Jun, Li, Pingping, Mohammadi, Moosa, Huang, Zhifeng
Publicado 2021